Effectiveness of attention-deficit/hyperactivity treatment and diagnosis methods tested.
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000628:therapy; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D015897:Comorbidity; D003891:Desipramine / Q000627:therapeutic use; D003913:Dextroamphetamine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D008297:Male; D008774:Methylphenidate / Q000627:therapeutic use; D009538:Nicotine / Q000627:therapeutic use; D010389:Pemoline / Q000627:therapeutic use; D010649:Phenylalanine / Q000627:therapeutic use
D000928:Antidepressive Agents; D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D010649:Phenylalanine; D009538:Nicotine; D010389:Pemoline; D008094:Lithium; D003891:Desipramine; D003913:Dextroamphetamine